Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria
- PMID: 18831691
- DOI: 10.1086/592715
Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria
Abstract
Sulfadoxine-pyrimethamine (SP) inhibits folate metabolism by the malaria parasite. We investigated the association between folate levels and SP failure in pregnant women. Data from a trial to assess the effect that folate supplementation has on SP failure in 467 pregnant women were analyzed. Plasma folate levels were determined at enrollment and at day 7. High baseline folate levels, high parasite densities, and age <20 years were risk factors for SP failure. High-dose (5 mg daily) folate supplementation or high folate levels at day 7 were independent risk factors. Therefore, pregnant women receiving SP should receive low-/moderate-dose folate supplementation.
Trial registration: http://www.clinicaltrials.gov identifier: NCT00130065.
Similar articles
-
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.Am J Trop Med Hyg. 2006 Jun;74(6):960-4. Am J Trop Med Hyg. 2006. PMID: 16760504 Clinical Trial.
-
Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.J Infect Dis. 2007 Nov 1;196(9):1403-8. doi: 10.1086/522632. Epub 2007 Oct 2. J Infect Dis. 2007. PMID: 17922406 Clinical Trial.
-
Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya.J Infect Dis. 2003 Feb 1;187(3):467-76. doi: 10.1086/367705. Epub 2003 Jan 24. J Infect Dis. 2003. PMID: 12552431
-
Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.J Antimicrob Chemother. 2014 Feb;69(2):323-30. doi: 10.1093/jac/dkt394. Epub 2013 Oct 14. J Antimicrob Chemother. 2014. PMID: 24126794 Review.
-
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.Trop Med Int Health. 2011 Jul;16(7):774-85. doi: 10.1111/j.1365-3156.2011.02765.x. Epub 2011 Apr 7. Trop Med Int Health. 2011. PMID: 21477099 Review.
Cited by
-
Malaria early in the first pregnancy: Potential impact of iron status.Clin Nutr. 2020 Jan;39(1):204-214. doi: 10.1016/j.clnu.2019.01.016. Epub 2019 Jan 26. Clin Nutr. 2020. PMID: 30737046 Free PMC article. Clinical Trial.
-
Micronutrient Status and Dietary Intake of Iron, Vitamin A, Iodine, Folate and Zinc in Women of Reproductive Age and Pregnant Women in Ethiopia, Kenya, Nigeria and South Africa: A Systematic Review of Data from 2005 to 2015.Nutrients. 2017 Oct 5;9(10):1096. doi: 10.3390/nu9101096. Nutrients. 2017. PMID: 28981457 Free PMC article. Review.
-
Safety and benefits of interventions to increase folate status in malaria-endemic areas.Br J Haematol. 2017 Jun;177(6):905-918. doi: 10.1111/bjh.14618. Epub 2017 Mar 29. Br J Haematol. 2017. PMID: 28369746 Free PMC article. Review.
-
Undernutrition and malaria in pregnancy - a dangerous dyad?BMC Med. 2016 Sep 19;14(1):142. doi: 10.1186/s12916-016-0695-2. BMC Med. 2016. PMID: 27645498 Free PMC article.
-
Effects and safety of periconceptional oral folate supplementation for preventing birth defects.Cochrane Database Syst Rev. 2015 Dec 14;2015(12):CD007950. doi: 10.1002/14651858.CD007950.pub3. Cochrane Database Syst Rev. 2015. PMID: 26662928 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
